Home | News | Find a Doctor | Ask a Question | Free

Prediction: Follica might try a reverse merger, too

If conventional sources of funding, like angel investors (should be well tapped-out by now), VCs, private placements, etc. don’t raise more money for them, and they’re unable to interest big pharmaceutical or biotech firms in buying them, I predict they may try a “reverse merger” too, like Histogen (soon to be Restorgenex) did.

And reverse merge with whom?

Do you know what a reverse merger is?

Aran, I can’t believe your questions there.

I didn’t say I knew who they might do this with, I was just predicting it’s a measure they might resort to, to try to raise money and go public while avoiding an IPO.

If you haven’t seen it already, Histogen has just signed a letter of intent to do this. Their new name will be Restorgenex.



Aderans might as well

Roger this method could be fine to “transform” a non-listed company into a listed company. However if the listed vehicle has not fresh money the new company should issue new shares to be sold to the public in order to get money. However I agree with you that this method could work and other histogen competitors could follow it.

Home | News | Find a Doctor | Ask a Question | Terms of Use & Privacy

This is an advertising site for paid advertisers to showcase successful hair restoration results only. It is not the mandate of this site to engage in the discussion of failed, unsuccessful procedures, lawsuits, litigations, refunds or complaint cases. Surgical hair restoration procedures carry risks. Please do thorough research, consult your own physician and investigate a doctor's background carefully before making a decision. By proceeding to use our site, you agree to abide by our Terms of Use & Privacy Policy at http://hairsite.com/terms-of-use/ where you can also find a list of HairSite's sponsoring physicians.